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G protein-coupled receptor (GPCR) kinases (GRKs) selec-
tively recognize and are allosterically regulated by acti-
vated GPCRs, but the molecular basis for this interaction is
not understood. Herein, we report crystal structures of
GRK6 in which regions known to be critical for receptor
phosphorylation have coalesced to stabilize the kinase
domain in a closed state and to form a likely receptor
docking site. The crux of this docking site is an extended
N-terminal helix that bridges the large and small lobes of
the kinase domain and lies adjacent to a basic surface of
the protein proposed to bind anionic phospholipids.
Mutation of exposed, hydrophobic residues in the N-term-
inal helix selectively inhibits receptor, but not peptide
phosphorylation, suggesting that these residues interact
directly with GPCRs. Our structural and biochemical
results thus provide an explanation for how receptor
recognition, phospholipid binding, and kinase activation
are intimately coupled in GRKs.
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Introduction
G protein-coupled receptor (GPCR) kinases (GRKs) belong to
the protein kinase A, G, and C (AGC) family, and phospho-
rylate Ser/Thr residues in the cytoplasmic loops and tails of
activated GPCRs. Receptor phosphorylation triggers a cas-
cade of events that includes the recruitment of arrestins,
uncoupling of GPCRs from heterotrimeric G proteins, recep-
tor internalization, and activation of G protein-independent
signal transduction pathways (Pitcher et al, 1998; Premont
and Gainetdinov, 2007). Although GRKs have a crucial func-
tion in desensitization, maladaptive GRK activity is impli-
cated in a range of human diseases, including heart failure
and opiate addiction (Pitcher et al, 1998; Metaye et al, 2005;
Dorn, 2009). GRKs are, therefore, considered important ther-
apeutic targets (Metaye et al, 2005; Premont and Gainetdinov,
2007; Dorn, 2009).
Similar to heterotrimeric G proteins and arrestins, GRKs
are able to discriminate between active and inactive GPCRs.
The molecular basis for how these protein families can
identify the activated state of almost any GPCR, despite
their great sequence divergence, is not well understood.
Various biophysical studies have predicted that as a receptor
progresses towards its fully active state, the cytoplasmic
surface of the GPCR expands and reorganizes to form a
binding site for its cellular partners (Rosenbaum et al,
2009). For example, in the recent crystal structure of opsin,
a GPCR with low constitutive activity, an amphipathic helical
peptide derived from the C-terminus of transducin (Gat–Ct)
binds directly to a small cavity formed by an outward twist
of the third cytoplasmic loop of the receptor (Scheerer et al,
2008). Because GRK activity is stimulated by agonist-occu-
pied GPCRs (Onorato et al, 1991; Palczewski et al, 1991; Chen
et al, 1993; Kim et al, 1993; McCarthy and Akhtar, 2002),
GRKs are believed to have, in addition to the canonical
phosphoacceptor-binding site in the kinase domain, a recep-
tor docking site that allosterically promotes kinase activity.
This docking site may take advantage of the same cavity
recognized by Gat–Ct. A molecular understanding of the
receptor docking site of GRKs could, therefore, provide signi-
ficant insight into not only the molecular basis for allosteric
activation of GRKs, but also the conformation and properties
of activated GPCRs.
Atomic structures for three of the seven vertebrate GRKs
have been reported (GRK1, GRK2, and GRK6), representing
each of the three vertebrate GRK subfamilies (Lodowski et al,
2003, 2006; Singh et al, 2008). In each case, the small (or N)
and large (or C) lobes of the kinase domain form interfaces
with the terminal and bundle lobes, respectively, of a reg-
ulator of G protein signalling homology (RH) domain
(Figure 1A). In none of the previously determined structures
does the kinase domain adopt a ‘closed’, active conformation
similar to the transition-state-like structure of protein kinase
A (PKA), wherein ATP and the catalytic machinery are
properly aligned with the phosphoacceptor peptide-binding
site (Madhusudan et al, 2002). Moreover, two structural
elements known to be critical for receptor phosphorylation
were either not fully ordered or not in a physiologically
relevant conformation. The first element is the highly con-
served N-terminus (residues 1 to B20), which is unique to
the GRK family of kinases. Truncation of the N-terminus
leads to nearly complete loss of receptor phosphorylation
(Yu et al, 1999; Noble et al, 2003; Huang et al, 2009), and the
binding of recoverin (Chen et al, 1995) or an antibody
(Palczewski et al, 1993) to this region in GRK1 blocks
phosphorylation of light-activated rhodopsin. The second
element is the AGC kinase carboxyl-terminal tail (C-tail), an
extension of the canonical protein kinase domain that has a
Received: 4 May 2010; accepted: 28 July 2010; published online:
20 August 2010
*Corresponding author. Life Sciences Institute, The University of
Michigan, 210 Washtenaw Avenue, Ann Arbor, MI 48109, USA.
Tel.: þ 1 734 615 9544; Fax: þ 1 734 763 6492;
E-mail: tesmerjj@umich.edu
3These authors contributed equally to this work
4Present address: WM Keck Structural Biology Laboratory, Cold Spring
Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724,
USA
The EMBO Journal (2010) 29, 3249–3259 | & 2010 European Molecular Biology Organization | All Rights Reserved 0261-4189/10
www.embojournal.org







Figure 1 Structure of the GRK6  sangivamycin complex. (A) The GRK6  sangivamycin dimer. As in prior crystal structures of GRK1 and GRK6,
the extreme C-termini form a non-physiological domain swap in the crystal lattice. The N-terminal 18 amino acids (green) of the enzyme form a
helix (aNT) whose C-terminal end packs between a region of the small lobe previously identified as being important for GPCR phosphorylation
(Huang et al, 2009) and the AGC kinase C-tail (magenta). The C-terminus of GRK6 (orange) winds between the RH (grey) and kinase (white)
domains and ends in an amphipathic helix (aCT) that docks between the RH and kinase domains. Sangivamycin and sulphate ions are shown
as sphere models with carbons coloured tan, nitrogens cyan, oxygens red, and sulphurs yellow. The same colour scheme is used for GRK6 and
ligands in all subsequent figures, unless otherwise indicated. (B) The kinase domain of the GRK6 AMPPNP complex (left, PDB entry 2ACX) is
more open and less ordered than that of the GRK6  sangivamycin complex (right). The orientation is the same as the right-most subunit in
panel A, with the C-terminal domain-swapped region of the second chain mapped back on the subunit. The GRK6 AMPPNP complex was
positioned by superimposing its small lobe with that in the sangivamycin complex. Both GRK6 structures are shown as sphere models except
for the N-terminus, C-tail, and C-terminal regions, which become better ordered as the kinase domain progresses to a more closed
conformation (right). Numbers indicate the amino-acid number at the ends of each ordered segment of the polypeptide chain. Arg190, a
residue previously shown to be critical for receptor and peptide phosphorylation (Huang et al, 2009), is coloured blue. A common divalent
anion-binding site was observed in each structure. A 11.51 rotation of the large lobe around an axis oriented out of the page, as indicated, is
required to superimpose the large lobe of the GRK6 AMPPNP complex with that of the GRK6  sangivamycin complex. An 81 clockwise rotation
of the bundle subdomain of the RH domain, around the axis indicated (bottom left), also occurs upon transition to the more closed state.
(C) Stereo view of the closed states of GRK6 (light grey) and protein kinase B (PKB, black). The two AGC kinases were superimposed using
their small lobes, showing that their large lobes are in a similar, relatively closed configuration. The AMPPNP ligand and glycogen synthase
kinase 3b (GSK3b) peptide (cyan) are from the structure of PKB (PDB entry 1O6L). The PKB C-tail (yellow) has a longer AST loop that interacts
with the same region of the small lobe as the C-terminal end of aNT in GRK6 (Figure 2).
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regulatory function in AGC kinases and that becomes increas-
ingly well ordered as the kinase approaches its active con-
formation (Kannan et al, 2007). The central segment of the
C-tail, known as the ‘active site tether’ (AST), passes over the
active site of the kinase domain and contains residues known
to be important for GRK activity (Huang et al, 2009; Sterne-
Marr et al, 2009).
Herein, we present new structures of GRK6 in a relatively
closed conformation, wherein both the N-terminus and C-tail
are well ordered and interact in a manner that is consistent
with their anticipated functions in stabilizing the active form
of the enzyme and in forming a docking site for activated
GPCRs. We also provide biochemical evidence that residues
at the extreme N-terminus of GRK6 interact directly with
receptors. These results allow generation of a model of the
GRK–GPCR complex that helps to explain how receptor and
phospholipid binding cooperatively stabilize the active state
of GRKs, and how GRKs are able to selectively recognize the
activated state of a GPCR.
Results
Structure of GRK6 in a closed conformation
We crystallized a palmitoylation-deficient mutant of human
GRK6 in complex with either the adenosine analogue sangi-
vamycin or AMP, and collected anisotropic diffraction data
to 2.7 and 2.9 Å spacings, respectively (Table I). As in prior
crystal structures of GRK6 and GRK1, the protein crystallized
as a dimer with a C-terminal domain swap forming part of the
two-fold interface (Figure 1A). However, strikingly different
from prior GRK structures, all of the regions known to be
critical for the phosphorylation of active GPCRs are ordered,
including the extreme N-terminus and the AST region of the
C-tail (Figure 1B), and have coalesced to stabilize the kinase
domain in a novel, relatively closed conformation. An addi-
tional 22 amino acids at the C-terminus also become ordered
(Figure 1B). Relative to the previously determined GRK6 
adenylyl-imidodiphosphate (AMPPNP) structure (Lodowski
et al, 2006), the large lobe of the kinase domain is rotated
11.51 towards the small lobe, severing its interactions with the
bundle lobe of the RH domain. In addition, the bundle lobe
of the RH domain has rotated B81 relative to its terminal
lobe (Figure 1B). Although an additional B71 rotation
of the large lobe is still required for the kinase domain to
adopt a conformation similar to the active states of PKA
(Madhusudan et al, 2002) or protein kinase B (PKB) (Yang
et al, 2002) (Figure 1C), the GRK6  sangivamycin/AMP struc-
tures represent the most complete and closed structures of a
GRK determined to date. Full domain closure may require the
binding of ATP and/or GPCRs.
An N-terminal helix stabilizes the closed conformation
of GRK6
Residues 2–18 of the GRK N-terminus form a single a helix
(aNT) that makes extensive interactions with conserved
residues in both the small lobe and C-tail known to be
Table I Crystallographic data and refinement statistics
Ligand (PDB entry): Sangivamycin (3NYN) AMP (3NYO)
X-ray source: APS beam line 21 ID-G APS beam line 21 ID-G
Wavelength (Å) 0.97856 0.97856
Dmin (Å) 2.7 (outer shell: 2.75–2.7) 2.9 (outer shell: 2.95–2.9)
Space group P61 P61
Cell constants (Å; deg) a¼ b¼ 154.6, c¼ 207.9; a¼b¼ 90, g¼ 120 a¼ b¼ 154.6, c¼ 208.1; a¼b¼ 90, g¼ 120
Unique reflections 77021 (3771) 61 817 (3071)
Unique reflections (ellipsoidal cutoff)a 45 850 (47) 34 428 (39)
Average redundancy 3.8 (3.1) 4.5 (4.4)
Average redundancy (ellipsoidal cutoff)a 3.9 (4.8) 4.4 (4.3)
Rsym (%) 9.9 (4100) 11.6 (4100)
Rsym (%; ellipsoidal cutoff)
a 8.8 (35.1) 10.8 (45.5)
Completeness (%) 99.9 (99.8) 100 (100)
Completeness (%; ellipsoidal cutoff)a 59.4 (1.2) 55.7 (1.3)
/IS//sIS 9.7 (0.21) 6.5 (0.21)
/IS//sIS (ellipsoidal cutoff)
a 19 (3.8) 15 (2.4)
Refinement resolution (Å) 30–2.7 (outer shell: 2.8–2.7) 30–2.9 (outer shell: 3.0–2.9)
Total reflections used 45 750 (154) 34 329 (109)
Protein atoms 8908 8908
Non-protein atoms 138 131
RMSD bond lengths (Å) 0.008 0.007
RMSD bond angles (deg) 1.0 1.0
Estimated coordinate error (Å) 0.20 0.27
Average B-factor (Å2)b 77 100
Ramachandran plot statistics
Most favoured, disallowed (%) 88.0, 0.0 86.1, 0.0
Rwork 20.1 (29.8) 21.0 (36.6)
Rfree
c 23.6 (36.8) 25.3 (31.3)
Rfinal
d 22.7 (49.5) 22.2 (28.2)
aDiffraction data extended to 3.5 Å along a* and b*, and to 2.7 Å along c* for the sangivamycin data set, and to 4.0 Å along a* and b*, and to 2.9
Å along c* for the AMP data set. Scaling was performed after rejection of observations outside a standard ellipsoid with these reciprocal space
dimensions. Table entries that specify an ellipsoidal cutoff are statistics calculated after application of the ellipsoidal cutoff, and thus
R-factors and completeness are lower for these entries.
bB-factor does not include the TLS contribution.
c5% of the data set was excluded from refinement to calculate Rfree.
dAll reflections were used in the final rounds of refinement.
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important for GRK activity against receptor and peptide
substrates (Huang et al, 2009; Sterne-Marr et al, 2009)
(Figure 2). Two of these residues, Arg190 in the small lobe
and Ile472 in the C-tail, seem to have particularly important
structural roles. Arg190 is found in a patch of residues on the
surface of the small lobe, relatively distant from the active
site, that are uniquely conserved in the GRK subfamily of
AGC kinases (‘site 1’ in Huang et al, 2009). However, in prior
GRK structures, the residues in this patch were solvent
exposed and/or poorly ordered, and thus their function in
catalysis was not clear. In the closed structure of GRK6, the
aliphatic portion of the Arg190 side chain packs against the
side chains of Ala8 and Leu12 in aNT, and its guanidinium
group forms bridging hydrogen bonds between the small
lobe, the side chain of Asn9 in aNT, and the backbone
carbonyl of Lys475 in the C-tail (Figure 2A and C). The
extensive contacts of Arg190 are consistent with prior muta-
genesis studies. Substitutions at this position with alanine in
GRK1, GRK2, and GRK6 resulted in nearly complete loss of
kinase activity, and even conservative substitution to lysine
in GRK1 was nearly as defective as truncation of the
N-terminal 15 amino acids of the enzyme (Huang et al,
2009). In the C-tail, the side chain of Ile472 is accommodated
in a hydrophobic pocket created by the side chains of Asn9,
Leu12, and Leu13 on aNT (Figure 2). Substitution of the
residue equivalent to GRK6-Ile472 in GRK1 and GRK2 also
resulted in a dramatic loss of kinase activity (Huang et al,
2009; Sterne-Marr et al, 2009). The extensive contacts of
Arg190 and Ile472 and the fact that their substitution leads
to diminished activity against both receptor and peptide
substrates both suggest that their function is to stabilize the
active conformation of GRK6—a state that is likely similar to
the closed conformation reported here.
Structure of the AGC kinase C-tail of GRK6
Unlike in previously determined GRK structures, the entire
AGC kinase C-tail of GRK6 (residues 452–502) is ordered, in
particular the AST region. The AST begins with the ‘AST
loop’, which is formed in GRK6 by a hydrogen bond between
the backbone amide of Asp468 and the side chain hydroxyl of
Tyr473. The loop is sandwiched between aNT and the large
lobe of the kinase domain (Figure 2A and B). In other AGC
kinase families, the AST loop is four residues longer and
these additional residues become ordered and interact with
the small lobe as the kinase domain adopts a more closed
conformation (Figure 1C). In GRKs, the loop is too short to
form an analogous ‘clasp’, leaving instead a shallow canyon
between the small lobe and C-tail that instead serves as the
docking site for the C-terminal end of aNT (Figure 2B). Thus,
from a structural standpoint, the C-terminal end of aNT
seems to compensate for the shorter AST loops of GRKs by
taking on the function of a stabilizing bridge between the
small and large lobes.
Two residues after the AST loop, the GRK6 C-tail follows a
unique path from those of other characterized AGC kinases
(Figures 1C and 2A). Residues 476–479 form a tight turn that
provides hydrogen bonds with residues in aNT. Mutation of
residues in GRK1 and GRK2 equivalent to GRK6-Ile480,
whose side chain packs between this tight turn and the
small lobe, results in significant defects in catalytic activity
(Huang et al, 2009; Sterne-Marr et al, 2009). The C-tail then
wanders across the small lobe and forms a belt around the aB
Figure 2 Intramolecular contacts of aNT. (A) The aNT helix and C-tail of the kinase domain form bridging interactions between the small and
large lobes that stabilize the closed state. Hydrogen bonds between aNT (green) and the C-tail (magenta) are shown as dashed lines. The side
chain of Phe273 in aD forms the most significant interaction between the large lobe and the C-tail. Sangivamycin, which occupies the ATP-
binding site, and a nearby sulphate ion are shown as spheres. (B) The aNT helix is the keystone in an arch of interactions that spans the
nucleotide-binding site and hinge region of the kinase domain. The view is directed at the C-terminal end of aNT, which is shown as a Ca trace.
The arch begins on the left, as shown, with the small lobe, followed by aNT, then the C-tail, and ends on the right with the aD helix of the large
lobe (Phe273). The side chains of Leu12 and Arg190 are adjacent and pack underneath the arch. Mutation of either residue dramatically
reduces GPCR and peptide phosphorylation (Table II) and (Huang et al, 2009), respectively. (C) Interaction network of Leu12 and Arg190 in the
context of the GRK primary sequence alignment. Hydrogen bonds mediated by Arg190 are shown with purple connecting lines, and dots
indicate bonds involving backbone atoms. Apolar contacts are shown with blue connecting lines. All sequences correspond to the human
enzyme.
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helix, whose surface exposed residues form another region
uniquely conserved in GRKs (‘site 2’ in Huang et al, 2009;
Figure 3A). This latter segment of the C-tail contains the
canonical AGC kinase ‘turn motif’, a site of auto-phospho-
rylation in some GRKs, but its location and structure is
distinct from that of PKA. The GRK6 C-tail ends, as it does
in PKB (Yang et al, 2002), by contributing a final helix and
short b-strand to the small lobe.
Membrane interaction surface of GRK6
The ability of a GRK to phosphorylate a GPCR is almost
always dependent on the presence of a negatively charged
membrane such as one that contains phosphatidylinositol
4,5-bisphosphate (PIP2) (Pitcher et al, 1996, 1998). Con-
sequently, GRKs are believed to contain structural elements
that facilitate their interactions with anionic head groups. An
intensely basic, relatively flat surface is found immediately
adjacent to the protruding N-terminal end of the aNT helix in
GRK6 (Figure 3A and B). Three sulphate anions from the
crystallization solution are bound to this surface (Figure 3C).
One of these sites was also occupied by a divalent anion in
the GRK6 AMPPNP structure, which was crystallized in the
absence of sulphate (Figures 1B and 3C), suggesting that it
represents a high-affinity-binding site for PIP2 (Pitcher et al,
1996). Residues involved in coordinating these anions are
highly conserved in the GRK4 subfamily, and bulk substitu-
tion of six of the N-terminal Arg/Lys residues in this region
with alanine ablated PIP2-dependent receptor phosphory-
lation in GRK5 (Pitcher et al, 1996). Interestingly, in this
same study, PIP2 did not stimulate the phosphorylation of
peptide substrates. Considered along with our structural data,
this suggests that although the basic region binds directly to
the cell membrane, such is still insufficient to stabilize the
closed state of the kinase domain.
A putative GPCR docking site
If the aforementioned lipid-binding surface is used to define
the plane of the lipid bilayer when GRK6 is at the cell
membrane (Figure 3), then the N-terminal end of aNT
would protrude into the plane of the membrane. Exposed
hydrophobic residues at the N-terminal end of aNT (Leu3,
Ile6, Val7, Thr10, and Val11) form a continuous hydrophobic
surface that could favourably interact with the hydrophobic
phase of the bilayer (Figures 2A and 3A). However, the
presence of two negatively charged residues at the N-termi-
nus of aNT in most GRKs (Glu2 and Glu4 in GRK6; Figure 2C)
argues against aNT serving as a membrane-binding element.
The highly conserved nature of residues that form this
hydrophobic surface (Figure 2A and C) is more consistent
with these residues comprising a functionally important
interaction site, such as one that might be formed with an
activated GPCR. In the crystal lattice, this hydrophobic
surface forms a short, anti-parallel coiled–coil interaction
with the same surface of a non-crystallographically related
aNT helix. This strong lattice contact likely plays a similar
role as an activated GPCR in that it stabilizes the aNT helix
and, consequently, the closed state of GRK6.
Mutational analysis of the GPCR docking site
If the aNT helix were important for direct interactions with
active receptors, then site-directed mutation of the exposed
hydrophobic residues in aNT should inhibit phosphorylation
of a GPCR, but not of a short peptide that contains the native
phosphoacceptor sites from the same receptor. We, therefore,
measured the ability of the GRK6C splice variant (Vatter et al,
2005) to phosphorylate bovine rod outer segments (bROS)
Figure 3 Membrane interacting surface of GRK6 in its closed con-
formation. (A) The expected membrane interacting surface of
GRK6. The view is from the perspective of the proposed phospho-
lipid bilayer. Three sulphate anions, which may correspond to
binding sites for phosphate groups in PIP2, bind to a relatively flat
region formed by residues 23–31 of the linker joining aNT and the
RH domain and by adjacent regions of the small lobe. Next to this
region, the N-terminal end of aNT projects into the expected plane
of the lipid bilayer and bears conserved, exposed hydrophobic
residues (green spheres). (B) Molecular surface of GRK6 coloured
by its electrostatic potential. The view is the same as in panel A. The
surface is coloured in a gradient from p–6 kT/e (red, acidic) to
X6 kT/e (blue, basic). The relatively flat region next to aNT,
which contains the divalent anion-binding sites, is exceptionally
basic and thus well suited to directly interact with the negatively
charged inner leaflet of the cell membrane. (C) Interactions
of residues in the proposed membrane binding region of GRK6.
All side chains shown are conserved in the GRK4 subfamily of
GRKs. The centrally positioned anion was observed in both the
AMPPNP (Lodowski et al, 2006) and sangivamycin/AMP com-
plexes. Hydrogen bonds are indicated by black dashed lines.
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and ‘peptide C’, which contains the known phosphoacceptor
sites from the C-terminus of rhodopsin (Table II). The I6A and
V7A mutations exhibited 12–13-fold defects in bROS phos-
phorylation, but no significant defect in peptide phosphor-
ylation, as predicted by our docking model. The I6A/V7A and
I6E/V7E double mutants exhibited 36- and 180-fold defects,
respectively, in receptor phosphorylation, a progression
consistent with the idea that these residues interact with a
hydrophobic surface, such as that provided by IL3 of an
activated GPCR. In contrast, residues from aNT that form
extensive interactions with the small lobe and C-tail, such as
Asn9 and Leu12 (Figure 2), exhibited significant defects in
both bROS and peptide phosphorylation, consistent with their
proposed function in stabilizing the active conformation of
the kinase domain. Our results are also consistent with the
defects in receptor phosphorylation reported for other mu-
tants in the N-termini of GRK5 and GRK2, with the exception
that we were unable to observe significant defects for
mutants of Leu3 and Asp4 in our assays (Yu et al, 1999;
Noble et al, 2003; Pao et al, 2009). This difference may simply
reflect the fact that different GRKs have different dependen-
cies on each of these residues when they interact with
specific GPCRs.
Ligand interactions in the kinase active site
We were able to co-crystallize GRK6 in this relatively
closed state in the presence of either sangivamycin or AMP.
The ligands bind similarly in the canonical ATP-binding
site that is formed between the small and large lobes of
the kinase domain, adjacent to the hinge joining the two
lobes, and directly underneath the C-tail (Figures 2B and 4).
Sangivamycin is a Streptomyces-derived adenosine analogue,
differing by a 7-deaza-7-carbamoyl substitution, long recog-
nized for its antitumor properties. It is a relatively potent GRK
inhibitor (Palczewski et al, 1990) and binds to GRK6 with a
KD of B1 mM, which is about 30-fold tighter than adeno-
sine (data not shown). The 7-carbamoyl substitution packs
deep in the GRK active site where it forms van der Waals
interactions with the side chains of Ser328 and the ‘gate-
keeper’ residue Leu263 (Figure 4A). Its amide group also
forms hydrogen bonds with the side chain of Asp329, a
residue that coordinates Mg2þ in AGC kinase complexes
with ADP or ATP, and with a buried water molecule that
also coordinates the backbone amide of Asp329.
Sangivamycin can be displaced out of the active site by
soaking crystals in the presence of adenine nucleotides
(data not shown), suggesting that the GRK C-tail is not acting
as a gate to lock ATP or its products in the active site. AMP
makes contacts analogous to those of the AMP moieties of
ADP or ATP in other AGC kinase structures, with its adenine
ring forming two specific hydrogen bonds with backbone
atoms in the hinge (Figure 4B). Unlike in PKA, residues in the
kinase C-tail make no direct contact with the bound ligands.
Sangivamycin was previously shown to be about five-fold
more potent against protein kinase C than PKA (Loomis and
Bell, 1988). AGC kinases other than GRKs and most PKC
isoforms have bulkier Thr/Val residues at the position
equivalent to GRK6-Ser328, which would sterically crowd
the 7-carbamoyl group (Figure 4A) and at least partially
explain the observed selectivity.
A structural function for the GRK6 C-terminus
The unique C-terminal regions of the three GRK subfamilies
(i.e. the region that extends beyond the end of the RH
domain) are expected to have functions in membrane target-
ing and, in at least some cases, allosteric activation (Pitcher
et al, 1998; Lodowski et al, 2005). An additional 22 residues
from the C-terminus of GRK6 are ordered in the
GRK6  sangivamycin/AMP structures compared with the
more open GRK6 AMPPNP complex (Figures 1B and 5).
The newly ordered C-terminal residues of GRK6 wind
through the cleft formed between the bundle and terminal
lobes of the RH domain, and end in an amphipathic helix
(aCT, residues 548–557) that bridges the bundle lobe of the
RH domain and the aJ region of the kinase domain (Figures
1A, B and 5). Conserved residues in the aCT helix that were
previously proposed to interact directly with the cell mem-
brane (Thiyagarajan et al, 2004) instead make interactions
with conserved regions of the RH and kinase domains that
are only possible when the kinase domain adopts its rela-
tively closed conformation. The palmitoylation sites that
occur several residues after the end of aCT (a region dis-
ordered in this structure) are thus relatively distant from the
expected membrane surface (Figures 3 and 6). However, this
observation is consistent with the fact that the GRK6C splice
variant, which lacks the palmitoylation sites entirely and
whose C-terminus is similar to the end of the observed
structure reported here, fully retains its ability to bind mem-
branes and phosphorylate activated GPCRs (Vatter et al,
2005). Palmitoylation is, therefore, dispensable for function
in GRK6, and the region C-terminal to aCT, and its modifica-
tions, may chiefly be involved in auto-regulation of the
adjacent kinase domain.
Discussion
We have determined new structures of GRK6 in a closed
conformation in which structural elements known to be
critical for GPCR phosphorylation are fully ordered. These
Table II Kinetic parameters for bROS and peptide C phosphoryla-
tion by GRK6C aNT variants









Wild type 1.7±1 1 0.14±0.10 1
L3A 0.90±0.7 2 0.12±0.09 1
E4A 0.60±0.3 3 0.088±0.005 2
I6A 0.14±0.1 12 0.11±0.01 1
V7A 0.13±0.06 13 0.10±0.06 1
I6A/V7A 0.05±0.004 36 0.14±0.09 1
I6E/V7E 0.0096±0.007 180 0.10±0.01 1
N9A 0.012±0.005 140 0.018±0.007 8
L12A 0.0016±0.0004 1100 0.022±0.02 6
L13A 0.28±0.1 6 0.026±0.002 5
For bROS, values represent mean±standard error of the linear
regression fit calculated from 3 to 6 independent experiments. For
peptide C phosphorylation, values shown represent mean±stan-
dard error of the non-linear regression fit calculated from 2 to 4
independent experiments. As the Michaelis–Menten plots are linear
for bROS and peptide up to the highest concentration tested (80 mM
and 4 mM, respectively), the kcat could not be determined with
confidence. Therefore, only kcat/KM values are provided.
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elements interact with each other using residues that are
uniquely conserved in GRKs and known to be important for
kinase activity. In this relatively closed state, the aNT helix is
the keystone in a bridge of interactions that begins with the
small lobe, followed by the C-terminal end of aNT, then the
AGC kinase C-tail, and ends with the aD helix of the large
lobe (Figure 2B). The exposed, conserved hydrophobic patch
at the N-terminal end of aNT, and its spatial relationship to
the proposed membrane-binding surface of GRK6 (Figure 3),
strongly suggest that it represents the crux of the docking site
for activated GPCRs. The balance of the mutagenesis data
that reported here (Table II) and in the literature supports this
conclusion. The GRK6  sangivamycin/AMP structures thus
represent a conformation that is likely very close to the
activated state of the enzyme and that serves as a reasonable
model for the activated, GPCR-bound state of all GRKs.
To model how aNT might interact with an activated
receptor, we compared the GRK6 structure to the recently
reported structure of the opsin Gat–Ct complex (Scheerer
et al, 2008). As proposed for the N-terminal end of aNT, the
C-terminal end of the C-terminal helix of the heterotrimeric
Ga subunit is a major determinant for binding and selective
recognition of activated receptors (Oldham and Hamm,
2006). In the opsin Gat–Ct complex, the fifth and sixth
transmembrane spans (TM5 and TM6) of the receptor are
twisted outward from the helical core, relative to dark-state
rhodopsin, to expose a hydrophobic surface on their inner
side to which the amphipathic Gat–Ct helix binds (Scheerer
et al, 2008). Interestingly, the Gat–Ct helix adopts a similar
angle with respect to the proposed membrane plane as the
aNT helix of GRK6 (Figures 3 and 6). Although the GRK6
aNT and Gat–Ct helices have opposite orientations, their
exposed hydrophobic residues can be superimposed to dock
GRK6 with opsin (Figure 6). Features in support of the
resulting model are that (1) it places both IL3 and the
C-terminus of the GPCR, either of which can be phosphory-
lated by GRKs provided sufficient length, within easy reach of
the active site cleft in the kinase domain; (2) it would readily
accommodate the variable lengths of IL3 that are found in
GPCRs; and (3) it provides an explanation for why both
anionic phospholipids and activated GPCRs are required for
GRK activity, as follows. GRKs are not very selective for any
given GPCR, but are selective for activated receptors. There
are, accordingly, no specific hydrogen bonds or packing
interactions predicted by our docking model, and the direct
interaction of aNT with the receptor is consequently of
relatively low affinity. Cooperative interaction of the GRK
with both activated receptor and anionic lipids is thus
required to achieve enough affinity to stabilize the closed,
active conformation of the GRK, which is complementary in
Figure 4 Ligands bound in the active site of GRK6. (A) Stereo view of sangivamycin bound to GRK6. The 3s|Fo||Fc| omit map for
sangivamycin is shown as a blue wire cage. The inhibitor is shown as a ball-and-stick model, and hydrogen bonds are depicted by black dashed
lines. The 7-deaza-7-carbamoyl substitution of the adenosine analogue forms three specific hydrogen bonds, and packs between the Leu263
and Ser328 side chains. Unlike in other characterized AGC kinases, the C-tail region does not make direct contacts with the bound ligand,
which may help explain why nucleotide binding alone does not induce kinase domain closure in GRKs (Lodowski et al, 2006; Singh et al,
2008). (B) Stereo view of AMP bound to GRK6. The electron density shown corresponds to a 3s|Fo||Fc| omit map for AMP.
Activation of GRKs
CA Boguth et al
&2010 European Molecular Biology Organization The EMBO Journal VOL 29 | NO 19 | 2010 3255
shape and electrostatic properties to the activated GPCR in its
membrane environment. In the case of GRK6, this comple-
mentary surface includes the aNT/C-tail region and the
adjacent basic membrane-binding surface (Figures 3 and 6).
Thus, GRKs simply have to search for a complementary
surface to recognize and specifically phosphorylate a broad
range of sequence-diverse, but active, receptors.
An assumption in interpreting our mutagenesis experi-
ments was that GRK6 adopts the same closed conformation
whether it is phosphorylating a peptide or a receptor. The fact
that truncations of the N-terminus of GRKs are deficient in
peptide phosphorylation (Huang et al, 2009) suggests that
aNT forms similar interactions to stabilize the closed state
with either receptor or peptide substrate, and consequently
that the open and closed states of GRKs are in equilibrium,
with the open, inactive state being favoured in solution
(Huang et al, 2009). GPCR and phospholipid binding could
facilitate catalysis by simply driving the equilibrium towards
the closed state. Peptides derived from the N-terminus of
GRKs are not helical in solution (Pao et al, 2009), and this
region is disordered in all but one prior GRK structure. Thus,
it seems likely that the free energy of GPCR binding helps to
constrain the aNT region in a helical conformation that can
better interact with and stabilize the closed conformation of
the kinase domain. Regardless of the precise mechanism, it is
clear from our data that receptor/membrane binding, as
mediated by the aNT helix and the adjacent basic region
of GRK6, is intimately coupled with allosteric activation,
because the GPCR docking site can only form in the closed
state of the GRK.
The N-terminus and C-tail were not the only structural
elements to become ordered in the closed conformation of
GRK6. Surprisingly, an additional 22 amino acids of the
C-terminus of GRK6 were also resolved and interact with
the RH and kinase domains using residues that are highly
conserved in the GRK4 subfamily and that are known to
influence kinase activity (Figure 5). The observed C-terminal
structure would place the palmitoylation sites of GRK6
Figure 5 Interdomain contacts of the C-terminus of GRK6. (A) The aCT helix docks between the bundle lobe of the RH domain and the aJ
region of the C-tail. Residues preceding aCTwind through the cleft between the bundle and terminal lobes of the RH domain. The fact that this
region is well ordered and dependent on the open conformation of GRK6 suggests that the C-terminus of GRK6 helps to stabilize the closed
state of the kinase domain. The last observed residue, Ser557, is four residues before a cysteine-rich sequence that is known to be palmitoylated
in vivo (see panel E). Of these cysteines, acylated Cys565 would be most capable of interacting with the membrane in our model of membrane-
bound GRK6 (Figure 6). It is possible that additional conformational changes could occur in GRK6 as a consequence of GPCR binding that
would bring Cys561 and Cys562 into closer proximity with the membrane plane. However, these post-translational modifications may serve
purposes other than membrane binding in the active state of GRK6 (see text and Figure 6). (B) The loop that precedes aCT forms an unusual
structure with two tight turns that also helps to coordinate a sulphate anion. Pro546 was modelled with a cis-peptide bond. (C) Interactions
between hydrophobic residues in aCTand the side chains of Arg455, Ala458, and Met460 from the C-tail, and Val92 from the bundle lobe of the
RH. All of these residues are conserved in the GRK4 subfamily (see panel E). (D) Conserved salt bridges formed among residues in aCTand the
RH domain. Mutation of Arg554 or of the hydrophobic residues in aCT (panel C) led to significantly reduced activity in GRK5 (Thiyagarajan
et al, 2004). (E) Sequence alignment of human GRK4 subfamily members, highlighting conserved residues involved in contacts at the
C-terminus. Residues involved in apolar contacts are coloured magenta, and acidic and basic residues involved in salt bridges are coloured red
and blue, respectively. Asterisks mark the residues that are known (GRK6) or anticipated (GRK4) to be palmitoylated (Stoffel et al, 1994;
Premont et al, 1996).
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(which are not conserved among GRKs) relatively far from
the predicted membrane plane (Figure 6), implying that the
GRK6 C-terminus has a function in stabilizing the closed,
receptor-bound state of GRK6. If so, the GRK6 C-terminus
function similarly to the C-terminal PH domain of GRK2,
which binds to Gbg subunits. The GRK2–Gbg interaction
is essential for membrane translocation of GRK2 in cells,
stimulates in vitro activity up to 10-fold, and protects the kinase
domain of GRK2 against proteolysis (Lodowski et al, 2005).
A dual function for a lipid-modified domain is not without
precedence among AGC kinases. In PKA, N-terminal myristoy-
lation enhances not only membrane association, but also
structural stability (Yonemoto et al, 1993). The myristoyl
group was in fact shown to pack in a hydrophobic pocket
formed between its N-terminal helix and the large lobe of the
kinase domain (Zheng et al, 1993).
In summary, our studies have revealed a unique allosteric
mechanism for the activation of an AGC kinase—one that
may ultimately afford new opportunities for the selective
targeting of GRKs by therapeutic agents. Further confirmation
of this model awaits analogous studies in other GRK sub-




Sangivamycin was purchased from Berry and Associates, Inc.
(Dexter, MI) and (2R,3R)-(-)-2,3-butanediol (97%) was purchased
from Sigma-Aldrich.
Protein purification
GRK6 (pal mutant) was purified as described previously (Lo-
dowski et al, 2006). GRK6 elutes as two peak fractions at B145 mM
(peak 1) and 160 mM NaCl (peak 2) from the Source S column.
Crystals could be grown with protein from either peak under similar
conditions.
Crystallization
Crystals of GRK6 (peak 1) were grown at 41C by hanging drop
vapour diffusion method by mixing 1ml protein solution with 1ml of
well solution. GRK6 (10 mg/ml) pre-mixed with 400mM sangiva-
mycin (in DMSO) and 200mM MgCl2 was used for crystallization
trials. Crystals were grown with well solution consisting of 1.9 M
ammonium sulphate and 100 mM Bis–Tris pH 5.2. Rod-like plates
appeared within a few days and grew to maximum dimensions of
500 505 mm in a week. For cryoprotection, crystals were soaked
in a solution consisting of 2.2 M ammonium sulphate, 100 mM
Bis–Tris pH 5.2, 20 mM HEPES pH 8, 200 mM NaCl, 2 mM DTT,
400 mM sangivamycin, 200 mM MgCl2, and 20% (2R,3R)-(-)-butane-
diol. Crystals could also be obtained under similar conditions by co-
crystallization with AMP. For these, hanging drops contained
10 mg/ml GRK6, 4 mM AMP pH 7.5, and 2 mM MgCl2 mixed in a
1:1 ratio with a well solution containing 1.6 M ammonium sulphate
and 100 mM Bis–Tris pH 5.2. The AMP crystals were cryo-protected
in a solution consisting of 1.8 M ammonium sulphate, 100 mM
Bis–Tris pH 5.2, 20 mM HEPES pH 8, 200 mM NaCl, 2 mM DTT,
4 mM AMP pH 7.5, 2 mM MgCl2, and 20% (2R,3R)-(-)-2,
3-butanediol. We were unable to grow crystals in the presence of
ADP or ATP analogues, perhaps because these compounds favour a
distinct, more closed conformation of the kinase domain that is
incompatible with the lattice of the P61 crystals.
Data collection and structure determination
Diffraction maxima were collected at LS-CAT beam line 21-ID-G
from crystals maintained at 110 K. The HKL2000 software package
was used for data reduction, and the structure of GRK6 (2ACX) was
used as a molecular replacement search model using PHASER
(Storoni et al, 2004) in the CCP4 suite (Winn, 2003). The model was
refined using REFMAC (Murshudov et al, 1997) alternating with
manual model building using O (Jones et al, 1991). Owing to the
high anisotropy of the data, ellipsoidal truncation of the data, as
described in Table I, was performed before scaling with SCALE-
PACK, as described previously (Lodowski et al, 2003). Truncation
lead to 2–3% reduction in working and free R-factors compared
with untruncated data, significantly improved the quality of the
electron density maps, and allowed the modelling of some solvent
molecules. Non-crystallographic symmetry restraints were imposed
on the two chains in the asymmetric unit throughout refinement.
The stereochemistry of the model was evaluated using PROCHECK
(Laskowski et al, 1993). The final refinement statistics are
summarized in Table I, and the final structure spans residues
2–557 (out of 576 total), with only residues 387–389 missing in the
aF-aG loop and 19 residues missing from the extreme C-terminus.
As in the previously reported GRK6 AMPPNP and GRK1 structures
(Lodowski et al, 2006; Singh et al, 2008), GRK6 crystallized as a
Figure 6 Hypothetical model of GRK6 bound to opsin. The side
chains of three exposed hydrophobic residues in aNT (Leu3, Ile6,
and Leu7) were aligned with the side chains of three residues in
the Gat–Ct peptide bound to opsin (Leu344, Leu341, and Ile340,
respectively) (PDB entry 3DQB). In the resulting complex, the
proposed phospholipid-binding surface of GRK6 (Figure 3) is
brought in close proximity to the expected plane of the phospho-
lipid bilayer as positioned by the opsin structure, and the aNT helix
packs between the second and third intracellular loops (IL2 and IL3)
of the receptor. GRKs that have additional residues at the
N-terminus (e.g. GRK1, which has three more than GRK6, see
Figure 2C) can still be accommodated by the large cleft between
IL3 and the C-terminus of the receptor. Furthermore, in this model
either a longer IL3 loop (as is common in other GPCRs) or the
cytoplasmic tail of rhodopsin (which extends an additional 22
amino acids beyond the last ordered residue in this model) can
readily access the kinase active site cleft and serve as phospho-
acceptors. As modelled, aNT does not penetrate as far into the core
of the receptor as the Gat–Ct peptide, which may help explain the
relative lack of selectivity of GRKs for specific GPCRs compared
with Ga subunits. It should be emphasized, however, that this
GRK6–opsin complex is at best a low-resolution model because
opsin is not a fully activated receptor, and the GRK6 model is close
to, but not yet in a fully closed conformation. There are also other
regions besides aNT that are likely involved in interactions
with GPCRs, such as residues that would come into contact with
IL1 and IL2.
Activation of GRKs
CA Boguth et al
&2010 European Molecular Biology Organization The EMBO Journal VOL 29 | NO 19 | 2010 3257
non-physiological domain-swapped dimer, with the swap involving
residues at the extreme C-terminus. Both subunits in the asym-
metric unit of the crystals are essentially identical and exist in
similar packing environments. Indeed, some datasets collected
clearly belong to a higher symmetry space group (P6122) with one
chain per asymmetric unit. The electron density maps were all
consistent with the N-terminal methionine being cleaved and the
second residue N-acetylated, as has been confirmed for other GRKs
expressed in ovarian insect cells (Pitcher et al, 1999; Singh et al,
2008). Final coordinates and structure factors are deposited in the
Protein Data Bank as entries 3NYN and 3NYO for the sangivamycin
and AMP complexes, respectively.
ROS and peptide phosphorylation assays
We used the GRK6C splice variant (Figure 5E) for kinetic assays
because it has higher reported activity towards bROS than other
splice forms (Vatter et al, 2005). cDNA coding for human GRK6C
with a non-cleavable hexa-histidine tag at the C-terminus was
cloned into the BamHI and EcoRI sites downstream of the
polyhedrin promoter in the pFastBac Dual vector (Invitrogen) to
create pFastBac-GRK6C-H6. Site-specific mutants were introduced
using the QuikChange Site-Directed Mutagenesis kit (Stratagene)
and all sequences were verified by DNA sequencing. Recombinant
protein was purified from high five insect cells as described
previously for GRK6-531-H6 (Huang et al, 2009). For bROS
phosphorylation, steady-state kinetics were conducted at saturating
ATP (0.5 mM) using 10–60 mM (80 mM in the case of wild-type
GRK6C) urea-washed bROS and 0.3–5 mM GRK mutants in 100 mM
HEPES-NaOH pH 7.5, 0.15 M NaCl, 10 mM MgCl2, and 1 mM EDTA
(Buffer A). The reaction was initiated by addition of ATP and then
incubated at room temperature (22–261C). We used relatively high
ionic strength (150 mM NaCl) in our reactions because we wished to
more closely emulate physiological conditions. For peptide C
phosphorylation, the reactions contained 0.9–10 mM GRK variant,
500mM ATP, and 0.23–4 mM peptide in Buffer A.
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